课题基金 / 基金详情

Fundamental Biophysical Study of the Antimicrobial Properties of Nisin for the Development of Novel Antibiotics

Fundamental Biophysical Study of the Antimicrobial Properties of Nisin for the Development of Novel Antibiotics
用于新型抗生素开发的乳链菌肽抗菌特性的基础生物物理研究
批准号:
2248362
负责人:
金额:
$0.0万
依托单位:
依托单位国家:
英国
项目类别:
Studentship
财政年份:
2019
资助国家:
英国
项目状态:
已结题
起止时间:
2019 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Antimicrobial resistance is an avoidable global and economic health threat, projected to be responsible for 10 million deaths per annum by 2050. Nisin is a polycyclic antimicrobial peptide which is active against multi-drug resistant strains of bacteria and non-toxic to humans, and has low resistance rates. Although Nisin demonstrates promising therapeutic potential, its mechanism of action remains poorly understood. Hence, there is a need to advance biophysical methodology and develop more effective chemical tools to probe Nisin's antimicrobial mode of action. Currently, it is understood that Nisin exhibits a dual mode of action, based on either sequestration of Lipid II, a key chemical involved in bacterial cell regulation, or nanopore formation to disrupt vital cell ion gradients. The latter hypothesis lacks, however, detailed characterization of nanopores. Research questions relate to the size, surface charges and stability of the nanopores, their kinetics of formation, and possible ion specificity. These questions will be addressed in the PhD project via electrophysiological techniques which have never been used for Nisin including pore sizing with polymers and ion flux measurements. In addition, thermodynamic methods such as isothermal titration will be applied to understand the membrane binding and multimerization mechanism. The newly gained biophysical insight will guide the structure-activity based organic synthesis of modern peptide therapeutics. By facilitating development of a new generation of antibiotics, our approach has the potential to benefit the pharmaceutical industry and global healthcare.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金